NEW YORK, Jan. 31 (UPI) -- A lawsuit by Nigerian families who say U.S. drugmaker Pfizer used their children in an illegal test of an experimental antibiotic can proceed, a court says.
LAGOS, Nigeria, June 6 (UPI) -- Pharmaceutical giant Pfizer is fighting back against a $7 billion lawsuit filed by the Nigerian government against the U.S. company.
ABUJA, Nigeria, May 30 (UPI) -- Pfizer faces criminal charges in Nigeria over a drug trial using children during a meningitis epidemic 11 years ago.
NEW YORK, Oct. 17 (UPI) -- The Austrian Patent Office has ruled for Pfizer Inc. in its patent fight over Lipitor's active ingredient against generic drug maker Ranbaxy. Ranbaxy, an Indian company, can appeal the ruling, but the patent will remain in effect during the appeals proces
SEOUL, April 19 (UPI) -- Pfizer Inc. is closing its Seoul pharmaceutical plant, a facility that makes the hypertension drug Norvasc.
NEW YORK, Dec. 27 (UPI) -- Pfizer Inc. has taken a $50 million, 12-percent stake in California-based Perlegen Sciences Inc., a DNA analysis firm.
WILMINGTON, Del., Dec. 19 (UPI) -- Pfizer Inc. has scored a legal victory against India's Ranbaxy Laboratories Ltd., pushing a global effort annul patent protections from Lipitor.
NEW YORK, Nov. 22 (UPI) -- New York-based Pfizer Inc. continued its string of legal victories against India's Ranbaxy Pharmaceuticals Inc., a generic drug maker.
WASHINGTON, Sept. 14 (UPI) -- The U.S. Food and Drug Administration rejected Pfizer Inc.'s application to market Oporia, a pill to treat osteoporosis, without explanation.
NEW YORK, Oct. 13 (UPI) -- A New York federal appeals court has revived a lawsuit against Pfizer Inc. over its study on Nigerian children, the Wall Street Journal reports.
